- Home
- / Jiangsu Aidea Pharmaceutical
Jiangsu Aidea Pharmaceutical
Stock Price
¥9
2024-10-29
Market Capitalization
¥3.8 B
2024-10-28
Revenue
¥706.3 M
FY, 2025
Jiangsu Aidea Pharmaceutical Summary
Company Summary
- Overview
- Jiangsu Aidea Pharmaceutical (江苏艾迪药业股份有限公司) is a company that produces and sells pharmaceutical protein products. It offers folium sennae granules, clindamycin hydrochloride capsules, sodium bicarbonate, nitrendipine, and metronidazole tablet.
- Type
- Public
- Status
- Active
- Founded
- 2009
- Website
- http://www.aidea.com.cn
- Cybersecurity rating
Table of Contents
Jiangsu Aidea Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥175.9M
- Gross profit (Q1, 2026)
- ¥118.1M
- Net income (Q1, 2026)
- ¥14.2M
- Cash (Q1, 2026)
- ¥503.9M
- EBIT (Q1, 2026)
- ¥20.0M
- Enterprise value
- $4.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026